Citi Reiterates $7 PT on Cano Health (CANO), Says Takeout Could Be Worth $14 on Roughly 2x Revenue

Go back to Citi Reiterates $7 PT on Cano Health (CANO), Says Takeout Could Be Worth $14 on Roughly 2x Revenue

Canaccord Sees One Clear Positive Catalyst for PayPal (PYPL)

September 26, 2022 12:18 PM EDT

In a wide-ranging note Monday, Canaccord analyst Kai Korschelt stated that despite a tough macro backdrop, they see one clear upcoming positive catalyst on the horizon for PayPal (NASDAQ: PYPL).

That positive catalyst is Pay with Venmo being launched on Amazon (NASDAQ: AMZN), which is expected to occur in the fourth quarter.

With... More

Affirm's (AFRM) Amazon (AMZN) Deal is 'Encouraging' - Morgan Stanley

September 23, 2022 2:06 PM EDT

Affirm Holdings (NASDAQ: AFRM) announced Friday that it is expanding its relationship with Amazon (NASDAQ: AMZN) to Canada, introducing a pay-over-time option to customers in the country in both English and French within the next month.

The company said customers who select... More

Cano Health (CANO) PT Lowered to $12 at UBS

September 23, 2022 6:51 AM EDT

UBS analyst Andrew Mok lowered the price target on Cano Health (NYSE: CANO) to $12.00 (from $14.00) while maintaining a Buy rating.... More

After-Hours Movers: Spectrum Pharm Sinks on Negative FDA Panel, Costco Dips on EPS

September 22, 2022 5:46 PM EDT

After-Hours Stock Movers:

Spectrum Pharmaceuticals (Nasdaq: SPPI) 28% LOWER; The FDA's Oncologic Drugs Advisory Committee (ODAC) met to review poziotinib for the treatment of patients with previously treated locally advanced or metastatic non-small cell lung cancer... More

4 Rumors Lighting Up Wall Street Today

September 22, 2022 4:43 PM EDT

Stocks closed lower again today but that didn't stop rumors from pushing several issues higher during the trading day. Below we highlight 4 rumors that were circling trading floors.

1. Cano Health (NYSE: CANO) jumped 32% on rumors Humana (NYSE:... More

Cano Health exploring sale after receiving buyout interest

September 22, 2022 4:12 PM EDT

By Anirban Sen, Greg Roumeliotis and David Carnevali

(Reuters) -U.S. primary care provider Cano Health is exploring a sale and working with advisors after receiving acquisition interest, according to people familiar with the matter.

Cano Health has received buyout interest from potential buyers including Humana Inc and CVS Health Corp, the sources said.

Cano, which went public last year through a merger with a special purpose acquisition company backed by billionaire Barry Sternlicht, received... More

Humana, CVS Health In the Running to Acquire Cano Health - Reports

September 22, 2022 4:05 PM EDT

According to a report from The Wall Street Journal, Thursday, Humana (NYSE: HUM) and others are interested in acquiring primary care provider Cano Health (NYSE: CANO), which is reported to be exploring a sale.

Citing people familiar with the matter,... More

CVS Health (CVS) Said to Consider Potential Bid for Cano Health (CANO) - Bloomberg

September 22, 2022 3:28 PM EDT

CVS Health (NYSE: CVS) Said to Consider Potential Bid for Cano Health (NYSE: CANO) - Bloomberg

... More

Cano Health (CANO) Said to Weigh Sale - Bloomberg

September 22, 2022 3:24 PM EDT

Cano Health (NYSE: CANO) Said to Weigh Sale - Bloomberg

Appears to confirm WSJ story moments ago
... More

Cano Health (CANO) Halted Moments Ago On Circuit Breaker

September 22, 2022 3:20 PM EDT

Cano Health (NYSE: CANO) Halted Moments Ago On Circuit Breaker

... More

Cano Health (CANO) April (2023) 7 and January (2024) 10 call spreaders active

September 22, 2022 3:20 PM EDT

Cano Health (NYSE: CANO) call put ratio 9.2 calls to 1 put with focus on April (2023) 7 and January (2024) 10 calls.

... More

Humana (HUM), Other Potential Buyers Circle Cano Health (CANO) - DJ

September 22, 2022 3:17 PM EDT

(Updated - September 22, 2022 3:19 PM EDT)

Humana (NYSE: HUM) and other potential buyers are interesting in Cano Health (NYSE: CANO), according to a report from Dow Jones, citing sources. A deal could be reached in the next several weeks.

... More